Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase

Peripheral decarboxylase inhibitors (PDIs) prevent conversion of levodopa to dopamine in the blood by the enzyme aromatic L-amino acid decarboxylase (AADC). Alterations in enzyme activity may contribute to the required higher dosages of levodopa observed in many patients with Parkinson’s disease. We...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:NPJ Parkinsons Dis
Autors principals: van Rumund, Anouke, Pavelka, Lukas, Esselink, Rianne A. J., Geurtz, Ben P. M., Wevers, Ron A., Mollenhauer, Brit, Krüger, Rejko, Bloem, Bastiaan R., Verbeek, Marcel M.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7979935/
https://ncbi.nlm.nih.gov/pubmed/33741988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41531-021-00172-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars